Results 191 to 200 of about 15,084 (212)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors

Oncologist, 2022
Justine Gantzer, Marco Moreira, François Bertucci   +2 more
exaly  

Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors

Journal of Cancer Research and Clinical Oncology, 2022
Jizhuang Luo, Alessio Campisi, Tangbing Chen   +2 more
exaly  

Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor

Clinical Lung Cancer, 2022
Yuki Shinno, Akihiko Yoshida, Yusuke Okuma   +2 more
exaly  

SMARCA4-deficient uterine sarcoma

International Journal of Gynecological Cancer
Yueying Yuan, Xiaozhuo Gao, Yong Zhang, Yanmei Zhu   +3 more
openaire   +2 more sources

Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohorts

Gynecologic Oncology, 2020
Diana Miao, Douglas I Lin, Brooke E Howitt   +2 more
exaly  

SMARCA4 mutated in SCCOHT

Nature Reviews Clinical Oncology, 2014
openaire   +1 more source

The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression

Histopathology, 2020
Shih-Chiang Huang, Ta-Sen Yeh, Chi-Tung Cheng   +2 more
exaly  

SMARCA4-Deficient Sarcoma

2020
openaire   +1 more source

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas

Journal of Thoracic Oncology, 2020
Natasha Rekhtman, Joseph Montecalvo, Jason C Chang   +2 more
exaly  

SMARCA4 Loss Is Very Rare in Thoracic Mesothelioma

American Journal of Surgical Pathology, 2019
Mahsa S, Ahadi, Anthony J, Gill
openaire   +2 more sources